Is The BMJ a Good Journal? Fit Verdict
A practical BMJ fit verdict for authors deciding whether the manuscript is broad enough and transparency-ready enough for this journal.
Research Scientist, Neuroscience & Cell Biology
Author context
Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.
Journal fit
See whether this paper looks realistic for The BMJ (British Medical Journal).
Run the Free Readiness Scan with The BMJ (British Medical Journal) as your target journal and see whether this paper looks like a realistic submission.
The BMJ at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 42.7 puts The BMJ in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~7% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: The BMJ takes ~~48 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to read The BMJ as a target
This page should help you decide whether The BMJ belongs on the shortlist, not just whether it sounds impressive.
Question | Quick read |
|---|---|
Best for | The BMJ publishes clinical research that helps doctors make better decisions. It sits in the top tier of. |
Editors prioritize | Research that helps doctors make better decisions |
Think twice if | No patient and public involvement |
Typical article types | Research, Analysis, Clinical Review |
Quick answer: The BMJ (IF 42.7, ~4% acceptance) is one of the Big 4 general medical journals, but it's the most distinctive of the four. Open peer review with published reviewer names, patient/public reviewers, qualitative research welcomed, authors retain copyright. If your paper helps clinicians or policymakers make a better decision and can survive public scrutiny, BMJ is a strong target.
The BMJ at a glance
Metric | Value |
|---|---|
Impact Factor (JCR 2024) | 42.7 |
Acceptance rate | ~4% |
Desk rejection rate | ~50% |
Peer review model | Open (reviewer names published) |
Patient/public reviewers | Yes, alongside academic reviewers |
Copyright | Retained by authors |
Qualitative research | Explicitly welcomed |
Primary care editor | Yes, dedicated (only Big 4 journal) |
Indexing | PubMed, Web of Science, Scopus |
What makes The BMJ different from the other Big 4
Most "is X a good journal" pages treat the Big 4 general medical journals as interchangeable prestige tiers. They're not. The BMJ has an editorial culture that's genuinely different from NEJM, Lancet, and JAMA, and that difference determines fit.
Open peer review. The BMJ publishes reviewer names alongside accepted papers. This is unique among the Big 4. It changes the review dynamic fundamentally: reviewers can't hide behind anonymity, which tends to produce more constructive and less adversarial feedback. It also means your reviewers are publicly accountable for their assessment.
Patient and public reviewers. Every research paper sent for external review also goes to a patient or public reviewer. They assess whether the research question matters to patients, whether the outcomes are meaningful, and whether the plain language summary actually communicates. No other Big 4 journal does this systematically.
The Hanging Committee. Final decisions on research papers happen at a weekly editorial meeting called the Hanging Committee. The panel includes a statistician and an external adviser alongside the editors. If your paper makes it past desk review and external peer review, it still has to survive a room where someone is specifically looking at your stats.
Authors retain copyright. Unlike NEJM, Lancet, and JAMA, BMJ authors keep their copyright. This matters for reuse, institutional repositories, and future derivative work.
How The BMJ compares
Journal | IF (2024) | Acceptance | Best for | Distinguishing feature |
|---|---|---|---|---|
NEJM | 78.5 | ~5% | Practice-changing US clinical trials | Gold standard for interventional evidence |
Lancet | 88.5 | ~5% | Global health, health equity, policy | International scope, editorials with political positions |
JAMA | 55.0 | ~7% | Broad US clinical practice and evidence synthesis | JAMA Network transfer pathway, structured abstracts |
The BMJ | 42.7 | ~4% | Evidence-based practice, primary care, transparency | Open review, patient reviewers, copyright retention |
PLOS Medicine | 9.9 | ~10% | Open-access general medicine | OA-first, broader acceptance threshold |
The IF gap between BMJ (42.7) and NEJM (78.5) or Lancet (88.5) leads some authors to treat BMJ as the "easier" Big 4 option. It's actually the most selective by acceptance rate (~4% vs ~5-7% for the others). The lower IF reflects citation patterns and readership geography, not editorial standards.
The BMJ's editorial sweet spots
Primary care research. The BMJ is the only Big 4 journal with a dedicated primary care editor. If your study was conducted in primary care, measures primary care outcomes, or has direct implications for GPs and family physicians, BMJ is the natural home. NEJM and JAMA publish primary care work occasionally; BMJ publishes it as a core editorial priority.
Qualitative and mixed-methods research. NEJM and JAMA rarely publish qualitative studies. The BMJ explicitly welcomes them. If your research uses interviews, focus groups, ethnographic observation, or mixed methods and has broad clinical or policy relevance, BMJ is one of very few high-impact options.
Health policy and systems research. Papers that address how healthcare is organized, funded, or delivered (not just what treatments work) find a receptive editorial team here.
Public health evidence with practice implications. COVID-era BMJ published some of the most-cited public health analyses. The journal has maintained that editorial posture.
Submit if
- Your paper helps clinicians, policymakers, or health systems make a better decision, and the evidence is strong enough to survive open peer review with published reviewer names
- Primary care research with population-level implications, BMJ is the only Big 4 with a dedicated editor for this
- Qualitative or mixed-methods work with broad clinical or policy consequence, NEJM and JAMA won't take it; BMJ will
- Your data-sharing and reporting transparency are already bulletproof (BMJ requires both)
- The manuscript reads well for generalists, not just specialists in one field
Journal fit
See whether this paper looks realistic for The BMJ (British Medical Journal).
Run the scan with The BMJ (British Medical Journal) as the target. Get a manuscript-specific fit signal before you commit.
Think twice if
- The real audience is one clinical specialty, BMJ wants broad medical relevance, not niche expertise
- Your paper is a randomized trial with decisive clinical evidence and US practice focus, NEJM is the more natural home
- You can't share your data or register your study, BMJ's transparency requirements aren't negotiable
- The statistical methods wouldn't survive a dedicated statistician at the Hanging Committee reviewing your paper
- You're choosing BMJ because it "seems easier than NEJM", at 4% acceptance, it's actually more selective by the numbers
The Christmas Issue: Not a joke (well, it is, but a rigorous one)
Every December, The BMJ publishes research that is intentionally humorous but methodologically sound. Past papers have studied the parachute as an intervention for gravitational challenge, the walking speed of zombies in horror films, and whether men really are babies when they get the flu. The papers use proper study design, real statistical analysis, and survive peer review. Publishing in the Christmas Issue is competitive and gets enormous readership, the parachute paper is one of the most-read BMJ articles ever. If you have a genuinely funny research question that can be answered with real methods, this is a legitimate publication route.
Practical shortlist test
- Would a GP in Manchester and an internist in Melbourne both find this paper useful? If yes, BMJ fits.
- Are you comfortable with your reviewers' names being published? If not, consider NEJM or JAMA (both use single-blind).
- Would a patient reviewer understand why this study matters? If you can't explain it in plain language, the patient reviewer will flag it.
- Does the paper survive a statistician's scrutiny at the Hanging Committee? If your methods section has hand-waving, fix it first.
Before you submit
A BMJ submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.
Not sure if your paper is BMJ-shaped? A BMJ clinical scope check can assess whether the broad-relevance and transparency packaging is ready before you submit.
Frequently asked questions
Yes. The BMJ is one of the Big 4 general medical journals with a 2024 impact factor of 42.7 and roughly 4% acceptance rate. It's unique among the Big 4 for its open peer review model (reviewer names are published), patient/public peer reviewers, and a dedicated primary care editor. Authors retain copyright, which is unusual at this level.
The BMJ accepts roughly 4% of research submissions. About 50% are desk-rejected before peer review. The weekly Hanging Committee (a panel including a statistician and external adviser) makes final decisions on papers that pass initial review.
Yes, and unusually so. The BMJ uses open peer review where reviewer identities are published alongside the paper. It also includes patient and public peer reviewers alongside academic reviewers, the only Big 4 journal to do this systematically. Reviewers know their names will be attached to their comments.
Yes. The BMJ explicitly welcomes qualitative and mixed-methods research, which sets it apart from NEJM and JAMA. If your study uses interviews, focus groups, or ethnographic methods and has broad clinical or policy relevance, BMJ is one of the few high-impact venues that will take it seriously.
Every December, The BMJ publishes its Christmas Issue featuring humorous but methodologically rigorous research. Topics have included whether surgical teams really leave instruments inside patients more on Fridays, and the aerodynamics of reindeer. Papers must be scientifically sound, the humor is in the question, not the methodology. It's one of the most-read issues of any medical journal each year.
Sources
- 1. The BMJ journal homepage, BMJ.
- 2. The peer review process | BMJ Author Hub, BMJ.
- 3. Patient and public partnership | BMJ Author Hub, BMJ.
- 4. Data sharing | BMJ Author Hub, BMJ.
- 5. Resources for reviewers | The BMJ, BMJ.
Final step
See whether this paper fits The BMJ (British Medical Journal).
Run the Free Readiness Scan with The BMJ (British Medical Journal) as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- BMJ (British Medical Journal) Submission Guide: What Editors Screen Before Review
- How to Avoid Desk Rejection at BMJ
- BMJ Review Time: What to Expect From Submission to Decision
- BMJ Acceptance Rate 2026: How Selective Is the Open Peer Review Journal?
- BMJ Impact Factor 2026: 42.7, Q1, Rank 5/332
- BMJ vs JAMA Oncology: Which Journal Should You Choose?
Compare alternatives
Supporting reads
Conversion step
See whether this paper fits The BMJ (British Medical Journal).
Anthropic Privacy Partner. Zero-retention manuscript processing.